Researchers in Oxford and London are running a survey to develop clear and appropriate counselling tools for APOE4 genetic testing – the most common genetic risk factor for Alzheimer’s disease. The survey explores motivations, concerns, and preferences for how APOE-related information and results should be communicated, with the aim of improving support for those learning their results. Participation is open to people with dementia, families and carers, professionals, and others with relevant perspectives. The survey can be completed within 10-15 minutes and is available here.
Date required
1 April 2026.
Organisation
Department of Psychiatry, University of Oxford
Contact
Clinical Trial Registration Details
N/A
This listing will expire Wednesday 1st April 2026 12:46pm